In-vivo administration of CLC-K kidney chloride channels inhibitors increases water diuresis in rats

Abstract

CLC-K blockers may represent a new class of drugs for the treatment of conditions associated with expanded extracellular volume, with a hopeful high therapeutic potential for hypertensive patients carrying ClC-K gain-of-function polymorphisms.